Results 31 to 40 of about 12,652 (218)

Retromolar Embryonal Rhabdomyosarcoma: A Case Report

open access: yesJBN (Jurnal Bedah Nasional), 2017
Background: embryonal rhabdomyosarcoma is common of rhabdomyosarcoma, usually in 5 years old child. Approximately 28% of embryonal rhabdomyosarcomas occur in head and neck area, and 0.04% of cases occur as intra-oral tumors.
Caryl Augustine Johanna   +1 more
doaj   +1 more source

Oral Rhabdomyosarcoma: a review [PDF]

open access: yes, 2012
Rhabdomyosarcoma (RMS) is a rare malignant soft tissue neoplasm comprised of cells derived from the primitive mesen¬chyme. About 35% of RMS arises in the head and neck, are are classified as parameningeal and non-parameningeal forms.
Sethi, Kanika   +2 more
core   +1 more source

Embryonal rhabdomyosarcoma in adults [PDF]

open access: yesCancer, 1983
A series of 54 cases of embryonal rhabdomyosarcomas in adults were studied. The neoplasms were classified according to anatomic site, size, histologic pattern, age, and sex of the patients and modality of treatment. The major anatomic sites were the extremities (21 cases), genitourinary organs (13 cases) and the trunk (nine cases).
R V, Lloyd, S I, Hajdu, W H, Knapper
openaire   +2 more sources

Embryonal rhabdomyosarcoma of nasopharynx [PDF]

open access: yesIndian Journal of Otolaryngology and Head & Neck Surgery, 1999
A rare case of Embryonal Rhabdomyosarcoma in a 5 year male child involving Nasopharynx with intracranial. secondaries is reported. The child presented with difficulty in breathing and swallowing with change of the voice and bleeding from nose and mouth off and on.
B S, Tuli, T L, Parmar
openaire   +2 more sources

Multimodality imaging of vaginal rhabdomyosarcoma

open access: yesIndian Journal of Radiology and Imaging, 2017
Rhabdomyosarcoma (RMS) is a malignant mesenchymal tumor arising from the embryonal muscle cells (rhabdomyoblasts), and is the most common soft tissue sarcoma in children and young adults accounting for 4–6% of all malignancies in this age group.
Richa S Chauhan   +4 more
doaj   +1 more source

Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors [PDF]

open access: yes, 2015
Dysregulation of the cell cycle and cyclin-dependent kinases (cdks) is a hallmark of cancer cells. Intervention with cdk function is currently evaluated as a therapeutic option in many cancer types including neuroblastoma (NB), a common solid tumor of ...
Eggert, Angelika   +8 more
core   +2 more sources

Pediatric primary orbital rhabdomyosarcoma

open access: yesJournal of Pediatric Surgery Case Reports, 2020
Introduction: Orbital rhabdomyosarcoma is the most common orbital malignancy of childhood, with approximately 4 or 5 new cases per year per million children younger under 20 years of age.
Ho Huu Thien   +4 more
doaj   +1 more source

Case Report: Pediatric Hepatic Rhabdomyosarcoma With Maximum Lifetime

open access: yesFrontiers in Medicine, 2022
Primary intrahepatic rhabdomyosarcoma is an extremely rare malignant tumor. Here, we describe a case of embryonal rhabdomyosarcoma of the liver in a 7-year-old boy without any symptoms.
Xu Li   +6 more
doaj   +1 more source

Three-dimensional treatment planning and treatment protocol in embryonal rhabdomyosarcoma and orthognathic surgery: A case report

open access: yesOral and Maxillofacial Surgery Cases, 2019
Rhabdomyosarcoma (RMS) is one of the most common soft tissue sarcomas encountered in paediatric patients. Embryonal rhabdomyosarcoma (ERMS), a variant of RMS, is observed in more than 70% of the cases and predominantly arises from head and neck region ...
Sohaib Shujaat   +4 more
doaj   +1 more source

Pharmacological targeting of the ephrin receptor kinase signalling by GLPG1790 in vitro and in vivo reverts oncophenotype, induces myogenic differentiation and radiosensitizes embryonal rhabdomyosarcoma cells [PDF]

open access: yes, 2017
EPH (erythropoietin-producing hepatocellular) receptors are clinically relevant targets in several malignancies. This report describes the effects of GLPG1790, a new potent pan-EPH inhibitor, in human embryonal rhabdomyosarcoma (ERMS) cell ...
Beirinckx, Filip   +20 more
core   +3 more sources

Home - About - Disclaimer - Privacy